EX-16.1 2 rgbp102016exh16_1.htm EXHIBIT 16.1

October 20, 2016

 

 

Office of the Chief Accountant

Securities and Exchange Commission

100 F Street, NE
Washington, D.C. 20549

 

 

Dear Sir/Madam:

 

We have read the statements included under Item 4.01 in the Form 8-K dated October 19, 2016 of Regen Biopharma, Inc. (the "Company") to be filed with the Securities and Exchange Commission regarding the change of auditors. We agree with such statements insofar as they relate to our firm.

 

Very truly yours,

 

/s/ Seale and Beers, CPAs

 

Seale and Beers, CPAs

Las Vegas, Nevada